➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Express Scripts
Boehringer Ingelheim
Harvard Business School
Colorcon

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

Dista Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for DISTA, and what generic and branded alternatives to DISTA drugs are available?

DISTA has eight approved drugs.



Summary for Dista
US Patents:0
Tradenames:6
Ingredients:6
NDAs:8

Drugs and US Patents for Dista

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dista ILOTYCIN erythromycin OINTMENT;OPHTHALMIC 050368-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Dista ILOTYCIN GLUCEPTATE erythromycin gluceptate INJECTABLE;INJECTION 050370-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Dista VALMID ethinamate CAPSULE;ORAL 009750-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Dista ERYTHROMYCIN ETHYLSUCCINATE erythromycin ethylsuccinate SUSPENSION;ORAL 062177-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Dista ILOTYCIN GLUCEPTATE erythromycin gluceptate INJECTABLE;INJECTION 050370-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Dista ILOTYCIN GLUCEPTATE erythromycin gluceptate INJECTABLE;INJECTION 050370-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Dista ILOSONE erythromycin estolate TABLET, CHEWABLE;ORAL 061895-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
McKesson
Baxter
McKinsey
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.